Table of Contents Author Guidelines Submit a Manuscript
Current Gerontology and Geriatrics Research
Volume 2011, Article ID 708154, 8 pages
http://dx.doi.org/10.1155/2011/708154
Review Article

Obesity and the Ageing Brain: Could Leptin Play a Role in Neurodegeneration?

School of Biology, University of Street Andrews, Bute Building, West burn Lane, St Andrews, Fife KY16 9TS, UK

Received 30 May 2011; Accepted 15 August 2011

Academic Editor: Eric Le Bourg

Copyright © 2011 G. H. Doherty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Ferri, M. Prince, C. Brayne et al., “Global prevalence of dementia: a Delphi consensus study,” The Lancet, vol. 366, no. 9503, pp. 2112–2117, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. 2011, http://www.ncbi.nlm.nih.gov/pubmed?term=neurodegeneration.
  3. E. Florencio Gama, J. Maria Santarém, E. Aparecido Liberti, W. Jacob Filho, and R. R. de Souza, “Exercise changes the size of cardiac neurons and protects them from age-related neurodegeneration,” Annals of Anatomy, vol. 192, no. 1, pp. 52–57, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. F. D. Dick, G. De Palma, A. Ahmadi et al., “Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study,” Occupational and Environmental Medicine, vol. 64, no. 10, pp. 666–672, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Kawahara and M. Kato-Negishi, “Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 276393, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. G. H. Doherty, “Boom and bust for homocysteine?” Central Nervous System Agents in Medicinal Chemistry, vol. 8, no. 2, pp. 107–120, 2008. View at Google Scholar · View at Scopus
  7. G. H. Doherty, “Leptin: a novel therapeutic target in the fight against neurodegeneration?” in Leptin: Hormonal Functions, Dysfunctions and Clinical Uses, R. M. Hemming and A. T. Belikin, Eds., Nova, 2011. View at Google Scholar
  8. “WHO (World Health Organization) Obesity and overweight. 2010,” 2011, http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf.
  9. K. L. Rennie and S. A. Jebb, “National prevalence of obesity: prevalence of obesity in Great Britain,” Obesity Reviews, vol. 6, no. 1, pp. 11–12, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. “Centers for Disease Control and Prevention,” 2011, http://www.cdc.gov/NCHS/data/hestat/obesity_adult_07_08/obesity_adult_07_08.pdf.
  11. E. C. Gorospe and J. K. Dave, “The risk of dementia with increased body mass index,” Age and Ageing, vol. 36, no. 1, pp. 23–29, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. J. Ho, J. L. Stein, X. Hua et al., “A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 18, pp. 8404–8409, 2010. View at Publisher · View at Google Scholar · View at PubMed
  13. W. Jagust, D. Harvey, D. Mungas, and M. Haan, “Central obesity and the aging brain,” Archives of Neurology, vol. 62, no. 10, pp. 1545–1548, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. A. Ward, C. M. Carlsson, M. A. Trivedi, M. A. Sager, and S. C. Johnson, “The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study,” BMC Neurology, vol. 5, article no. 23, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. I. Soreca, C. Rosano, J. Richard Jennings et al., “Gain in adiposity across 15 years is associated with reduced gray matter volume in healthy women,” Psychosomatic Medicine, vol. 71, no. 5, pp. 485–490, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. B. Martínez de Morentin, L. Varela, J. Fernø, R. Nogueiras, C. Diéguez, and M. López, “Hypothalamic lipotoxicity and the metabolic syndrome,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 350–361, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. K. N. Manolopoulos, L. O. Klotz, P. Korsten, S. R. Bornstein, and A. Barthel, “Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress,” Molecular Psychiatry, vol. 15, no. 11, pp. 1046–1052, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. J. A. Luchsinger, “Diabetes, related conditions, and dementia,” Journal of the Neurological Sciences, vol. 299, no. 1-2, pp. 35–38, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. N. Hoggard, J. G. Mercer, D. V. Rayner, K. Moar, P. Trayhurn, and L. M. Williams, “Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization,” Biochemical and Biophysical Research Communications, vol. 232, no. 2, pp. 383–387, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. Mix, A. Widjaja, O. Jandl et al., “Expression of leptin and leptin receptor isoforms in the human stomach,” Gut, vol. 47, no. 4, pp. 481–486, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Morash, A. Li, P. R. Murphy, M. Wilkinson, and E. Ur, “Leptin gene expression in the brain and pituitary gland,” Endocrinology, vol. 140, no. 12, pp. 5995–5998, 1999. View at Google Scholar · View at Scopus
  23. J. L. Halaas, K. S. Gajiwala, M. Maffei et al., “Weight-reducing effects of the plasma protein encoded by the obese gene,” Science, vol. 269, no. 5223, pp. 543–546, 1995. View at Google Scholar · View at Scopus
  24. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Google Scholar · View at Scopus
  25. L. A. Tartaglia, M. Dembski, X. Weng et al., “Identification and expression cloning of a leptin receptor, OB-R,” Cell, vol. 83, no. 7, pp. 1263–1271, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Bjørbæk, J. K. Elmquist, P. Michl et al., “Expression of leptin receptor isoforms in rat brain microvessels,” Endocrinology, vol. 139, no. 8, pp. 3485–3491, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. K. Elmquist, C. Bjørbæk, R. S. Ahima, J. S. Flier, and C. B. Saper, “Distributions of leptin receptor mRNA isoforms in the rat brain,” Journal of Comparative Neurology, vol. 395, no. 4, pp. 535–547, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Fei, H. J. Okano, C. Li et al., “Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 13, pp. 7001–7005, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. G. Mercer, N. Hoggard, L. M. Williams, C. B. Lawrence, L. T. Hannah, and P. Trayhurn, “Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization,” FEBS Letters, vol. 387, no. 2-3, pp. 113–116, 1996. View at Google Scholar · View at Scopus
  31. M. Y. Wang, Y. T. Zhou, C. B. Newgard, and R. H. Unger, “A novel leptin receptor isoform in rat,” FEBS Letters, vol. 392, no. 2, pp. 87–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Kloek, A. K. Haq, S. L. Dunn, H. J. Lavery, A. S. Banks, and M. G. Myers, “Regulation of Jak kinases by intracellular leptin receptor sequences,” Journal of Biological Chemistry, vol. 277, no. 44, pp. 41547–41555, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. Y. Gong, R. Ishida-Takahashi, E. C. Villanueva, D. C. Fingar, H. Münzberg, and M. G. Myers, “The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms,” Journal of Biological Chemistry, vol. 282, no. 42, pp. 31019–31027, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. J. You, Y. Yu, L. Jiang et al., “Signaling through Tyr985 of leptin receptor as an age/diet-dependent switch in the regulation of energy balance,” Molecular and Cellular Biology, vol. 30, no. 7, pp. 1650–1659, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. P. Hekerman, J. Zeidler, S. Bamberg-Lemper et al., “Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines,” FEBS Journal, vol. 272, no. 1, pp. 109–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. G. H. Doherty, C. Oldreive, and J. Harvey, “Neuroprotective actions of leptin on central and peripheral neurons in vitro,” Neuroscience, vol. 154, no. 4, pp. 1297–1307, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. D. Cota, K. Proulx, K. A. Blake Smith et al., “Hypothalamic mTOR signaling regulates food intake,” Science, vol. 312, no. 5775, pp. 927–930, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. B. Burguera, M. E. Couce, J. Long et al., “The long form of the leptin receptor (OB-Rh) is widely expressed in the human brain,” Neuroendocrinology, vol. 71, no. 3, pp. 187–195, 2000. View at Google Scholar · View at Scopus
  39. J. G. Mercer, K. M. Moar, D. V. Rayner, P. Trayhurn, and N. Hoggard, “Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice,” FEBS Letters, vol. 402, no. 2-3, pp. 185–188, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. P. A. Bennett, K. Lindell, C. Karlsson, I. C. A. F. Robinson, L. M. S. Carlsson, and B. Carlsson, “Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen,” Neuroendocrinology, vol. 67, no. 1, pp. 29–36, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. P. L. Thurlby and P. Trayhurn, “The role of thermoregulatory thermogenesis in the development of obesity in genetically-obese (ob/ob) mice pair-fed with lean siblings,” British Journal of Nutrition, vol. 42, no. 3, pp. 377–385, 1979. View at Google Scholar · View at Scopus
  42. D. R. Garris and B. L. Garris, “Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background,” Pathobiology, vol. 71, no. 5, pp. 231–240, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. I. S. Farooqi, J. M. Keogh, S. Kamath et al., “Metabolism: partial leptin deficiency and human adiposity,” Nature, vol. 414, no. 6859, pp. 34–35, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. C. T. Montague, I. S. Farooqi, J. P. Whitehead et al., “Congenital leptin deficiency is associated with severe early-onset obesity in humans,” Nature, vol. 387, no. 6636, pp. 903–908, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. A. Strobel, T. Issad, L. Camoin, M. Ozata, and A. D. Strosberg, “A leptin missense mutation associated with hypogonadism and morbid obesity,” Nature Genetics, vol. 18, no. 3, pp. 213–215, 1998. View at Google Scholar · View at Scopus
  46. G. H. Doherty, “Homocysteine: more than just a matter of life and death,” Experimental Neurology, vol. 205, no. 1, pp. 5–8, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. P. J. Scarpace, M. Matheny, R. L. Moore, and N. Tümer, “Impaired leptin responsiveness in aged rats,” Diabetes, vol. 49, no. 3, pp. 431–435, 2000. View at Google Scholar · View at Scopus
  48. C. Fernández-Galaz, T. Fernández-Agulló, F. Campoy et al., “Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats,” Journal of Endocrinology, vol. 171, no. 1, pp. 23–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Wang, Y. T. Zhou, T. Kakuma et al., “Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling,” Biochemical and Biophysical Research Communications, vol. 277, no. 1, pp. 20–26, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. S. Peralta, J. M. Carrascosa, N. Gallardo, M. Ros, and C. Arribas, “Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction,” Biochemical and Biophysical Research Communications, vol. 296, no. 2, pp. 425–428, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. C. D. Morrison, C. L. White, Z. Wang et al., “Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age,” Endocrinology, vol. 148, no. 1, pp. 433–440, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. R. S. Ahima, C. Bjorbæk, S. Osei, and J. S. Flier, “Regulation of neuronal and glial proteins by leptin: implications for brain development,” Endocrinology, vol. 140, no. 6, pp. 2755–2762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Dicou, S. Attoub, and P. Gressens, “Neuroprotective effects of leptin in vivo and in vitro,” NeuroReport, vol. 12, no. 18, pp. 3947–3951, 2001. View at Google Scholar · View at Scopus
  54. F. Zhang, S. Wang, A. P. Signore, and J. Chen, “Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia,” Stroke, vol. 38, no. 8, pp. 2329–2336, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. Z. Weng, A. P. Signore, Y. Gao et al., “Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling,” Journal of Biological Chemistry, vol. 282, no. 47, pp. 34479–34491, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. Z. Guo, H. Jiang, X. Xu, W. Duan, and M. P. Mattson, “Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization,” Journal of Biological Chemistry, vol. 283, no. 3, pp. 1754–1763, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. R. Pérez-González, D. Antequera, T. Vargas, C. Spuch, M. Bolós, and E. Carro, “Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of alzheimer's disease,” Journal of Alzheimer's Disease, vol. 24, supplement 2, pp. 17–25, 2011. View at Publisher · View at Google Scholar · View at PubMed
  58. L. J. Shanley, A. J. Irving, and J. Harvey, “Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity,” The Journal of Neuroscience, vol. 21, no. 24, p. RC186, 2001. View at Google Scholar · View at Scopus
  59. Y. Oomura, N. Hori, T. Shiraishi et al., “Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats,” Peptides, vol. 27, no. 11, pp. 2738–2749, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. X. L. Li, S. Aou, Y. Oomura, N. Hori, K. Fukunaga, and T. Hori, “Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents,” Neuroscience, vol. 113, no. 3, pp. 607–615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. S. J. Greco, K. J. Bryan, S. Sarkar et al., “Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 19, no. 4, pp. 1155–1167, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. W. Lieb, A. S. Beiser, R. S. Vasan et al., “Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging,” Journal of the American Medical Association, vol. 302, no. 23, pp. 2565–2572, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. Y. Ban, T. Watanabe, T. Suguro et al., “Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia,” Journal of Atherosclerosis and Thrombosis, vol. 16, no. 3, pp. 179–187, 2009. View at Google Scholar · View at Scopus
  64. K. Utsunomiya, T. Shinkai, S. Sakata et al., “Lack of association between the leptin receptor gene (LEPR) Gln223Arg polymorphism and late-onset alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 24, no. 1, pp. 101–103, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. D. A. Power, J. Noel, R. Collins, and D. O'Neill, “Circulating leptin levels and weight loss in Alzheimer's disease patients,” Dementia and Geriatric Cognitive Disorders, vol. 12, no. 2, pp. 167–170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Li, R. Zhao, K. Gao et al., “Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease,” Current Alzheimer Research, vol. 8, no. 1, pp. 67–80, 2011. View at Publisher · View at Google Scholar
  67. C. García-Cáceres, E. Fuente-Martán, E. Burgos-Ramos et al., “Differential acute and chronic effects of leptin on hypothalamic astrocyte morphology and synaptic protein levels,” Endocrinology, vol. 152, no. 5, pp. 1809–1818, 2011. View at Publisher · View at Google Scholar · View at PubMed
  68. Y. Arai, M. Takayama, Y. Abe, and N. Hirose, “Adipokines and aging,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 7, pp. 545–550, 2011. View at Google Scholar
  69. R. A. Whitmer, E. P. Gunderson, E. Barrett-Connor, C. P. Quesenberry, and K. Yaffe, “Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study,” British Medical Journal, vol. 330, no. 7504, pp. 1360–1362, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. C. S. Mantzoros, F. Magkos, M. Brinkoetter et al., “Leptin in human physiology and pathophysiology,” American Journal of Physiology-Endocrinology and Metabolism, vol. 301, no. 4, pp. E567–E584, 2011. View at Publisher · View at Google Scholar · View at PubMed
  71. R. N. Kalaria, “Vascular basis for brain degeneration: faltering controls and risk factors for dementia,” Nutrition Reviews, vol. 68, no. 2, pp. s74–s87, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. J. Harvey, “Leptin: the missing link in Alzheimer disease?” Clinical Chemistry, vol. 56, no. 5, pp. 696–697, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. C. E. Oldreive, J. Harvey, and G. H. Doherty, “Neurotrophic effects of leptin on cerebellar Purkinje but not granule neurons in vitro,” Neuroscience Letters, vol. 438, no. 1, pp. 17–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. W. C. Benzing, J. R. Wujek, E. K. Ward et al., “Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice,” Neurobiology of Aging, vol. 20, no. 6, pp. 581–589, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. C. W. Olanow, J. H. Kordower, and T. B. Freeman, “Fetal nigral transplantation as a therapy for Parkinson's disease,” Trends in Neurosciences, vol. 19, no. 3, pp. 102–109, 1996. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Meyer, E. R. Matarredona, R. W. Seiler, J. Zimmer, and H. R. Widmer, “Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures,” Neuroscience, vol. 108, no. 2, pp. 273–284, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. G. H. Doherty, “Developmental switch in the effects of TNFα on ventral midbrain dopaminergic neurons,” Neuroscience Research, vol. 57, no. 2, pp. 296–305, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. J. Harvey, “Leptin regulation of neuronal excitability and cognitive function,” Current Opinion in Pharmacology, vol. 7, no. 6, pp. 643–647, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. L. J. Shanley, A. J. Irving, M. G. Rae, M. L. J. Ashford, and J. Harvey, “Leptin inhibits rat hippocampal neurons via activation of large conductance calcium-activated K+ channels,” Nature Neuroscience, vol. 5, no. 4, pp. 299–300, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. M. Durakoglugil, A. J. Irving, and J. Harvey, “Leptin induces a novel form of NMDA receptor-dependent long-term depression,” Journal of Neurochemistry, vol. 95, no. 2, pp. 396–405, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. C. Schulz, K. Paulus, and H. Lehnert, “Central nervous and metabolic effects of intranasally applied leptin,” Endocrinology, vol. 145, no. 6, pp. 2696–2701, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. S. Fliedner, C. Schulz, and H. Lehnert, “Brain uptake of intranasally applied radioiodinated leptin in Wistar rats,” Endocrinology, vol. 147, no. 5, pp. 2088–2094, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. E. Beretta, M. G. Dube, P. S. Kalra, and S. P. Kalra, “Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes,” Pediatric Research, vol. 52, no. 2, pp. 189–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Boghossian, N. Ueno, M. G. Dube, P. Kalra, and S. Kalra, “Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin,” Neurobiology of Aging, vol. 28, no. 10, pp. 1594–1604, 2007. View at Publisher · View at Google Scholar · View at PubMed
  85. M. G. Dube, E. Beretta, H. Dhillon, N. Ueno, P. S. Kalra, and S. P. Kalra, “Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels,” Diabetes, vol. 51, no. 6, pp. 1729–1736, 2002. View at Google Scholar · View at Scopus